Search

everythinglearnresearchcommunity

for

Search:↓

Female hair loss linked to metabolic syndrome, not in males.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Dissolvable microneedles with Ginsenoside Rg3 can help treat hair loss by improving drug delivery and stimulating hair growth.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

EDA2R gene linked to hair loss.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Severe baldness on the top of the head is linked to a higher chance of heart disease, especially in men under 60.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

The document concludes that managing PCOS requires a comprehensive approach, including lifestyle changes and medication, to improve symptoms and reduce health risks.

Tofacitinib helped regrow hair in most patients with severe hair loss.

The removed ovarian tumor was a rare type of blood vessel tumor that improved the patient's symptoms and hormone levels after surgery.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.

Hair loss may indicate higher heart risk and metabolic issues.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Microemulsions could improve how drugs are delivered and absorbed in the body.

Some skin diseases may indicate a higher risk of metabolic syndrome and related health issues.

Medications for PCOS don't seem to raise heart disease risk.